av/larimar-therapeutics--big.svg

NASDAQ:LRMR

Larimar Therapeutics

  • Stock

USD

Last Close

8.05

30/08 20:00

Market Cap

584.11M

Beta: 0.17

Volume Today

162.95K

Avg: 214.37K

PE Ratio

−8.34

PFCF: −12.08

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.58M
-
1.57M
1.01%
-120K
107.66%
-104K
13.33%
average payables
4.92M
-
5.03M
2.28%
2.80M
44.45%
3.31M
18.20%
3.56M
7.85%
3.09M
13.41%
2.15M
30.44%
1.67M
22.08%
1.48M
11.27%
average receivables
661.50K
-
835K
26.23%
646.50K
22.57%
1.24M
91.96%
847K
31.75%
95K
88.78%
120K
26.32%
104K
13.33%
book value per share
0.01
-
75.85
885,115.09%
53.51
29.45%
34.22
36.06%
34.73
1.50%
-0.08
100.22%
7.55
10,120.68%
3.75
50.28%
4.31
14.72%
1.86
56.76%
capex per share
-0.00
-
-0.27
5,608,306.86%
-0.29
8.72%
-0.02
91.71%
-0.04
67.15%
-0.01
77.60%
-0.01
42.08%
-0.02
271.84%
-0.00
79.99%
-0.00
3.76%
capex to depreciation
-3.63
-
-8.50
134.48%
-3.11
63.37%
-0.29
90.60%
-0.41
41.44%
-1.06
157.16%
-0.40
62.41%
-1.02
155.37%
-0.31
69.21%
-0.53
67.69%
capex to operating cash flow
0.00
-
0.01
386.47%
0.01
27.10%
0.00
90.11%
0.00
66.99%
0.00
74.32%
0.00
59.82%
0.01
438.30%
0.00
54.14%
0.00
35.13%
capex to revenue
cash per share
0.01
-
83.01
876,231.87%
56.80
31.58%
44.64
21.40%
43.96
1.52%
4.78
89.12%
7.80
63.03%
4.08
47.61%
4.60
12.57%
1.98
57.00%
days of inventory on hand
days payables outstanding
1.51K
-
days sales outstanding
debt to assets
0.06
-
0.03
47.47%
0.00
90.87%
0.19
6,045.19%
0.17
10.57%
2.89
1,603.33%
0.06
97.84%
0.08
22.56%
0.04
43.93%
0.06
35.12%
debt to equity
0.07
-
0.04
47.79%
0.00
91.17%
0.26
7,566.37%
0.22
13.46%
-21.64
9,878.24%
0.07
100.34%
0.09
28.24%
0.05
47.67%
0.07
39.17%
dividend yield
earnings yield
-0.00
-
-5.30
5,444,879.85%
-8.00
51.05%
-4.93
38.43%
-4.62
6.29%
-2.26
51.00%
-0.17
92.64%
-0.27
63.28%
-0.32
18.28%
-0.18
42.43%
enterprise value
375.86B
-
-15.18M
100.00%
-21.53M
41.81%
-10.22M
52.55%
-15.40M
50.72%
9.32M
160.50%
192.79M
1,969.59%
121.11M
37.18%
84.98M
29.83%
178.55M
110.11%
enterprise value over ebitda
-10.58K
-
0.20
100.00%
0.38
84.78%
0.20
46.53%
0.25
24.97%
-0.40
260.44%
-4.50
1,018.64%
-2.40
46.72%
-2.33
3.06%
-4.31
85.17%
ev to operating cash flow
-13.31K
-
0.25
100.00%
0.41
62.49%
0.23
43.67%
0.30
28.17%
-0.41
237.23%
-4.57
1,013.24%
-2.88
37.04%
-3.08
7.16%
-5.34
73.12%
ev to sales
free cash flow per share
-0.00
-
-26.98
1,161,904.64%
-23.14
14.23%
-19.18
17.12%
-19.21
0.18%
-2.47
87.13%
-3.56
43.83%
-2.47
30.48%
-1.07
56.56%
-0.77
28.69%
free cash flow yield
-0.00
-
-4.29
5,697,232.76%
-7.28
69.65%
-4.15
42.95%
-3.88
6.50%
-2.23
42.60%
-0.17
92.54%
-0.23
37.95%
-0.26
13.49%
-0.17
35.27%
graham net net
0.01
-
74.49
886,695.26%
52.56
29.44%
33.01
37.19%
33.78
2.33%
4.33
87.19%
6.53
51.03%
3.26
50.17%
4.00
22.69%
1.65
58.62%
graham number
0.02
-
238.45
991,395.35%
175.03
26.60%
132.37
24.37%
133.63
0.95%
2.06
98.46%
24.59
1,092.35%
15.73
36.04%
11.34
27.93%
5.94
47.63%
income quality
0.77
-
0.80
3.55%
0.90
12.02%
0.84
6.29%
0.84
0.30%
0.98
16.96%
0.99
1.23%
0.83
16.29%
0.78
6.22%
0.91
16.13%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
interest coverage
40.84
-
156.05
282.09%
-167.80
207.52%
-54.58
67.47%
248.46
555.21%
13.14
94.71%
114.86
-
interest debt per share
0.00
-
2.65
483,495.71%
0.33
87.52%
9.17
2,671.26%
7.59
17.22%
1.44
81.06%
0.55
61.87%
0.35
36.24%
0.20
43.50%
0.13
36.06%
inventory turnover
invested capital
0.07
-
0.04
47.79%
0.00
91.17%
0.26
7,566.37%
0.22
13.46%
-21.64
9,878.24%
0.07
100.34%
0.09
28.24%
0.05
47.67%
0.07
39.17%
market cap
375.91B
-
14.02M
100.00%
7.23M
48.42%
10.56M
46.00%
13.29M
25.87%
10.23M
23.07%
254.42M
2,387.66%
185.20M
27.21%
106.39M
42.55%
199.75M
87.75%
net current asset value
104.12M
-
168.11M
61.46%
121.00M
28.02%
77.63M
35.84%
92.84M
19.59%
-1.15M
101.23%
82.96M
7,345.24%
57.95M
30.15%
105.24M
81.60%
75.96M
27.82%
net debt to ebitda
1.42
-
0.39
72.51%
0.50
28.33%
0.41
18.61%
0.47
14.49%
0.04
91.57%
1.44
3,552.65%
1.27
11.79%
0.59
53.83%
0.51
12.75%
net income per share
-0.00
-
-33.32
1,110,435.77%
-25.44
23.63%
-22.76
10.55%
-22.85
0.40%
-2.51
89.01%
-3.56
41.88%
-2.93
17.71%
-1.33
54.73%
-0.84
36.57%
operating cash flow per share
-0.00
-
-26.71
1,152,772.83%
-22.85
14.46%
-19.15
16.17%
-19.17
0.10%
-2.46
87.15%
-3.55
44.14%
-2.45
30.92%
-1.07
56.37%
-0.76
28.78%
payables turnover
0.24
-
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.31
-
-0.39
26.24%
-0.44
11.94%
-0.49
12.14%
-0.50
2.21%
-4.45
782.46%
-0.40
90.91%
-0.64
58.17%
-0.27
57.71%
-0.39
42.42%
revenue per share
roe
-0.35
-
-0.44
25.45%
-0.48
8.24%
-0.67
39.90%
-0.66
1.09%
33.33
5,165.92%
-0.47
101.42%
-0.78
65.51%
-0.31
60.54%
-0.45
46.69%
roic
-0.32
-
-0.42
30.88%
-0.48
16.19%
-0.56
16.02%
-0.53
4.91%
-1.61
202.45%
-0.42
74.21%
-0.66
58.04%
-0.29
55.78%
-0.45
56.48%
sales general and administrative to revenue
shareholders equity per share
0.01
-
75.85
885,115.09%
53.51
29.45%
34.22
36.06%
34.73
1.50%
-0.08
100.22%
7.55
10,120.68%
3.75
50.28%
4.31
14.72%
1.86
56.76%
stock based compensation to revenue
tangible asset value
104.44M
-
169.11M
61.92%
121.73M
28.02%
78.22M
35.74%
93.27M
19.25%
-694K
100.74%
89.69M
13,023.92%
64.41M
28.18%
110.90M
72.17%
81.72M
26.31%
tangible book value per share
0.01
-
75.85
885,115.09%
53.51
29.45%
34.22
36.06%
34.73
1.50%
-0.08
100.22%
7.55
10,120.68%
3.75
50.28%
4.31
14.72%
1.86
56.76%
working capital
110.30M
-
171.57M
55.55%
121.00M
29.47%
97.63M
19.32%
108.02M
10.64%
-1.15M
101.06%
88.96M
7,869.43%
63.36M
28.78%
110.03M
73.67%
80.67M
26.69%

All numbers in USD (except ratios and percentages)